Ingevity Corp: directors' dealings · United States · SEC (Form 4)

About Ingevity Corp

Ingevity Corp. (NYSE: NGVT) is a U.S.-listed specialty materials company headquartered in North Charleston, South Carolina, United States. The company develops advanced carbon, engineered materials, specialty polymers, and specialty chemicals for demanding industrial applications. Its business model is centered on technical differentiation, customer formulation support, and application performance rather than commodity-scale volume. Ingevity currently reports three operating segments: Performance Materials, Advanced Polymer Technologies, and Performance Chemicals. Performance Materials includes activated carbon technologies used in emissions control and filtration. Advanced Polymer Technologies includes caprolactone-based specialty polymers used in coatings, adhesives, elastomers, and related industrial applications. Performance Chemicals covers specialty chemicals and pavement technologies, including products used in agriculture, infrastructure, and road-marking applications. Ingevity’s roots go back to the legacy operations of Westvaco and later WestRock. The company was separated into an independent public company in May 2016, giving it a long industrial heritage while allowing management to sharpen the portfolio around higher-value specialty businesses. Ingevity also emphasizes a roughly 90-year legacy of innovation tied to its underlying technology platforms. Today, the group says it operates from multiple locations worldwide, supporting a geographically diversified commercial footprint across North America and other international markets. From a competitive standpoint, Ingevity occupies a niche position in the specialty chemicals and materials landscape. Its strengths lie in technical barriers to entry, product qualification cycles, and the ability to serve end markets where performance, reliability, and regulatory compliance matter. Key end uses include automotive components, emissions capture, asphalt paving, coatings, agrochemicals, lubricants, bioplastics, and pavement markings. This makes the company exposed to several end markets, but also gives it a portfolio of products that are embedded in mission-critical processes and infrastructure. Recent developments highlight an active portfolio reshaping effort. In 2025 and 2026, Ingevity continued to streamline its asset base through divestitures and strategic reviews of non-core businesses, including actions tied to parts of its industrial specialties and road-markings activities. The company’s 2025 results showed resilience in the underlying business despite a volatile macro backdrop, while early 2026 updates confirmed that management remains focused on improving mix, reducing complexity, and strengthening free cash flow generation. For investors, NGVT therefore represents a specialty materials story on the NYSE with a restructuring angle: the long-term equity case depends on execution, margin discipline, and the successful repositioning of the portfolio toward higher-quality specialty applications.